Strategic Wealth Partners’s BioNTech BNTX Stock Holding History

Strategic Wealth Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42	Closed	-$3.73K	–	1475
2026 Q1	$3.73K	Hold	42	–	–	﹤0.01%	1087
2025 Q4	$4K	Buy	+42	New	+$4.23K	﹤0.01%	1099

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Strategic Wealth Partners's BNTX Position: Q2 2026 in Review

Strategic Wealth Partners sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 42 shares — an estimated $3.73K sold.

Strategic Wealth Partners first reported a position in BNTX in Q4 2025 and held it in 2 quarters. The position peaked at $4K in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Strategic Wealth Partners reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
Strategic Wealth Partners sold 42 BioNTech shares in Q2 2026, an estimated $3.73K.
Strategic Wealth Partners first reported a position in BioNTech in Q4 2025 and held it in 2 quarters.
Strategic Wealth Partners's BioNTech position peaked at $4K in Q4 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.